Key Events This Week
31 Aug: New 52-week high at Rs.921.7
1 Sep: New 52-week high at Rs.952.2 and intraday low amid price pressure
3 Sep: New 52-week high of Rs.962.05
4 Sep: New 52-week high at Rs.974.9
Sep 18, 11:07 AM
BSE+NSE Vol: 5.13 lacs

Shilpa Medicare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
With a remarkable 123.65% gain over the past year, Shilpa Medicare Ltd surged to a fresh 52-week high of Rs 980.65 on 7 Sep 2026, defying the broader market’s subdued tone and showcasing a powerful technical momentum that has captivated market watchers.
Read full news article
31 Aug: New 52-week high at Rs.921.7
1 Sep: New 52-week high at Rs.952.2 and intraday low amid price pressure
3 Sep: New 52-week high of Rs.962.05
4 Sep: New 52-week high at Rs.974.9

With a remarkable 132.05% gain over the past year, Shilpa Medicare Ltd surged to a fresh 52-week high of Rs 974.9 on 4 Sep 2026, showcasing a powerful momentum that has captivated market attention amid a mixed broader market backdrop.
Read full news article
Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 962.05 on 3 Sep 2026, marking a remarkable rally from its low of Rs 260 just a year ago. This impressive price momentum is underpinned by a confluence of bullish technical indicators and sustained upward trends across multiple timeframes.
Read full news article
Shilpa Medicare Ltd experienced a notable intraday decline on 1 Sep 2026, touching a low of Rs 876.95, down 7.69% from previous levels. The stock underperformed its sector and broader market indices despite recent gains, reflecting immediate price pressures and a shift in market sentiment.
Read full news article
Surging from a 52-week low of Rs 260 to a fresh peak of Rs 952.2 on 1 Sep 2026, Shilpa Medicare Ltd has more than tripled in value over the past year, showcasing remarkable price momentum despite a broadly subdued market backdrop.
Read full news article
Surging past its previous peaks, Shilpa Medicare Ltd touched a new 52-week high of Rs 921.7 on 31 Aug 2026, marking a remarkable rally that has more than tripled the stock price from its 52-week low of Rs 260. This milestone comes amid a backdrop of strong technical momentum and sustained price appreciation, even as the broader market struggles to find footing.
Read full news articleSubmission of Scrutinizers Report on 39th AGM Resolutions along with Voting Results
Proceedings of 39th Annual General Meeting.
Shilpa Medicares Novel Complex Injectable OERIS (Ondansetron Extended - Release Injection 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing authorization.
No Upcoming Board Meetings
Shilpa Medicare Ltd has declared 60% dividend, ex-date: 04 Sep 26
Shilpa Medicare Ltd has announced 1:2 stock split, ex-date: 06 Nov 15
Shilpa Medicare Ltd has announced 1:1 bonus issue, ex-date: 03 Oct 25
No Rights history available